Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase II Emphasis
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Enhance the Capacity and Capabilities of Tennessee's Human and Animal Food Testing Laboratories in Support of an Integrated Food Safety System
Blocking Arsenicals-induced Cutaneous Injury
Reproductive Physiology of Gonadotropin Synthesis
Inhibition of oral bacterial biofilm formation using natural products-inspired or
Cancer Clinical Epidemiology Training Grant
Recently added grants:
Endothelial cell dysfunction in cerebral aneurysm pathogenesis
Non-coding RNA regulation of early neural development
Brain-invading monocytes promote the deleterious consequences of status epilepticus
Diversity MATTERS in Neuroscience Training
Dissecting molecular mechanisms implicated in age- and osteoarthritis-related decline in anabolism in articular cartilage
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM62201-5-0-2
Application #
7568588
Study Section
Project Start
2006-01-01
Project End
2008-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Early Therapeutics Development with Phase II Emphasis
/ University of Chicago
$662,981
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
Vokes, Everett E. /
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
Comments
Be the first to comment on this grant